Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanasios Dimopoulos

Showing results (81-90 of 283) with videos related to

Pageof 29
Sort By:
Gynecologic Oncology Reports|August 9, 2020
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19Michalis Liontos, Maria Kaparelou, Emmanouil Karofylakis, et al.
Oncotarget|January 7, 2020
Prognostic role of microRNAs in breast cancer: A systematic reviewEleni Zografos, Flora Zagouri, Despoina Kalapanida, et al.
Leukemia & Lymphoma|January 19, 2008
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphomaTheofanis Economopoulos, Amanda Psyrri, George Fountzilas, et al.
Gynecologic Oncology Reports|July 14, 2021
Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literatureMichalis Liontos, Oraianthi Fiste, Danai Drakopoulou, et al.
The Science of the Total Environment|January 15, 2021
A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaksDimitrios Paraskevis, Evangelia Georgia Kostaki, Nikiforos Alygizakis, et al.
BMC Cancer|December 5, 2024
Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignanciesAngeliki Andrikopoulou, Flora Zagouri, Kallirroi Goula, et al.
Cancers|August 27, 2021
MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor TreatmentAngeliki Andrikopoulou, Almog Shalit, Eleni Zografos, et al.
Blood Advances|April 30, 2025
Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based RegimensBrendan Saunders, Foteini Theodorakakou, Despina V Fotiou, et al.
American Journal of Hematology|April 2, 2026
The Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma With Renal Impairment: A Systematic ReviewIoannis Ntanasis-Stathopoulos, Sotirios Manganas, Charalampos Filippatos, et al.
Oncotarget|October 22, 2021
TP53 mutations determined by targeted NGS in breast cancer: a case-control studyAngeliki Andrikopoulou, Evangelos Terpos, Spyridoula Chatzinikolaou, et al.
Pageof 29

Showing results (81-90 of 283) with videos related to

Sort By:
Pageof 29
Gynecologic Oncology Reports|August 9, 2020
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19Michalis Liontos, Maria Kaparelou, Emmanouil Karofylakis, et al.
Oncotarget|January 7, 2020
Prognostic role of microRNAs in breast cancer: A systematic reviewEleni Zografos, Flora Zagouri, Despoina Kalapanida, et al.
Leukemia & Lymphoma|January 19, 2008
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphomaTheofanis Economopoulos, Amanda Psyrri, George Fountzilas, et al.
Gynecologic Oncology Reports|July 14, 2021
Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literatureMichalis Liontos, Oraianthi Fiste, Danai Drakopoulou, et al.
The Science of the Total Environment|January 15, 2021
A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaksDimitrios Paraskevis, Evangelia Georgia Kostaki, Nikiforos Alygizakis, et al.
BMC Cancer|December 5, 2024
Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignanciesAngeliki Andrikopoulou, Flora Zagouri, Kallirroi Goula, et al.
Cancers|August 27, 2021
MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor TreatmentAngeliki Andrikopoulou, Almog Shalit, Eleni Zografos, et al.
Blood Advances|April 30, 2025
Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based RegimensBrendan Saunders, Foteini Theodorakakou, Despina V Fotiou, et al.
American Journal of Hematology|April 2, 2026
The Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma With Renal Impairment: A Systematic ReviewIoannis Ntanasis-Stathopoulos, Sotirios Manganas, Charalampos Filippatos, et al.
Oncotarget|October 22, 2021
TP53 mutations determined by targeted NGS in breast cancer: a case-control studyAngeliki Andrikopoulou, Evangelos Terpos, Spyridoula Chatzinikolaou, et al.
Pageof 29